Latest Headlines

  1. SmartPath Dx Is Changing Pathology Image By Image, Minute By Minute 10/24/2023

    Smart Health Diagnostics Company ("SHDx" or "the Company"), a developer of precision diagnostic tests and imaging technologies that address unmet clinical needs for advancing today's standards of care, today announced its upcoming participation in Octane's Medical Innovation Forum 2023 to discuss SmartPath Dx's impact on human health in the pathology digital space within a panel setting.

  2. Gestalt And Pramana Announce Availability Of Integrated Digital Pathology Solutions And AI-Powered Platform 10/23/2023

    Gestalt Diagnostics, Inc., a leading provider of artificial intelligence (AI) powered digital pathology solutions, and Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, announced a new integrated digital and AI-powered platform for laboratories, health systems, and academic medical centers.

  3. Volition Presents Breakthrough Liquid Biopsy Blood Test Method For Early-Stage Cancer 10/23/2023

    VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has unveiled what it believes to be an entirely new cancer detection method at ESMO 2023¹, the annual congress of the European Society for Medical Oncology.

  4. Foundation Medicine Expands Partnership With Sequanta To Provide Both Liquid And Tissue Genomic Profiling Services In China To Support Global Regulatory Filings 10/21/2023

    Foundation Medicine, Inc., today announced that it has expanded its partnership with Sequanta Technologies Co., Ltd. (“Sequanta”) to provide genomic profiling services to support clinical research and the development of oncology therapies in China.

  5. Thermo Fisher Scientific Signs Companion Diagnostic Agreement With Boehringer Ingelheim To Select Patients With NSCLC For Targeted Therapy Treatment 10/19/2023

    To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targeted cancer treatments, Thermo Fisher Scientific today announced a companion diagnostic (CDx) partnership with Boehringer Ingelheim.

  6. Roswell Park Licenses Rapid, Comprehensive Blood Test To Agilent, A Global Leader In The Life Sciences Market 10/19/2023

    An advanced, high-speed blood cancer test developed at Roswell Park Comprehensive Cancer Center has been licensed for commercial development by Agilent Technologies Inc., a global leader in life sciences, diagnostics and applied markets.

  7. Avalon Globocare Partners With Qi Diagnostics To Co-Develop International Multi-Center Clinical Studies For Dkair Breathalyzer Device For The Early Detection Of Diabetic Ketoacidosis 10/18/2023

    Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced that it has partnered with Qi Diagnostics Limited (“Qi Diagnostics”) to co-develop international multi-center clinical studies for DKAir™ breathalyzer device for the early detection of diabetic ketoacidosis (“DKA”).

  8. Roche IL-6 Is The First Immunoassay Approved To Aid Sepsis Diagnosis In Newborns 10/18/2023

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Elecsys IL-6 immunoassay has become the first IL-6 test to have a certified claim for use in diagnosis of neonatal sepsis, in countries accepting the CE Mark.*

  9. Gwangju Institute Of Science And Technology Scientists Develop Deep Learning-Based Biosensing Platform To Count Viral Particles Better 10/18/2023

    Rapid and on-site diagnostic technologies for identifying and quantifying viruses are essential for planning treatment strategies for infected patients and preventing further spread of the infection.

  10. Flowmeter Software Driver For Chromatography Data Systems 10/18/2023

    TESTA Analytical announce a powerful new software driver that allows control and collection of data from any of its AB-4XXXX Series liquid flowmeters using a chromatography data system (CDS) which supports the Agilent Technologies rapid control framework (rc.NET).